Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06908538 · ClinicalTrials.gov registry record
Cryo NerVe Block Extremity AmputatioN RegIStry for Post Operative and pHantom Limb Pain
A clinical trial of Amputation and Amputation, Traumatic/Surgery, sponsored by AtriCure.
- Recruiting
- Registry status
- 2,000
- Enrollment target
- 4
- Study locations
NCT06908538: Recruiting study of Amputation and Amputation, Traumatic/Surgery, sponsored by AtriCure.
NCT06908538 is a study of Amputation and Amputation, Traumatic/Surgery that is actively recruiting participants, run by AtriCure. The registered enrollment target is 2,000 participants, above the 102-participant average among 65 other Amputation trials with a reported enrollment target (1861% higher). The trial reports 4 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06908538, a study of Amputation and Amputation, Traumatic/Surgery, is actively recruiting participants, sponsored by AtriCure.
- RECRUITING
- Registry status
- 2,000 participants
- Enrollment target
- 4
- Study locations
Study Summary
The goal of this Registry is to see how the device is used when freezing nerves during an amputation procedure.
Primary Outcome
CryoNerve Block procedural complications
Conditions Studied
Interventions
- DEVICE cryoablation
Study Locations (4)
Massachusetts
- Berkshire Medical Center - Pittsfield
New Hampshire
- Elliot Hospital - Manchester
New York
- NYU Langone Health - New York
Wisconsin
- Medical College of Wisconsin/Froedtert Hospital - Milwaukee
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,000 participants |
| Start Date | 2025-04-01 |
| Est. Completion | 2035-04 |
What NCT06908538 shows while recruiting
NCT06908538 is an observational study that tracks outcomes without assigning an intervention. Its 2,000 participants enrollment target places it among the larger protocols in the corpus, above the 102-participant average among 65 other Amputation trials with a reported enrollment target (1861% higher).
The record links to 6 conditions, with Amputation appearing as the primary indexed condition, and to 1 intervention - of which cryoablation is the first listed.
NCT06908538 reports a single indexed study location in Massachusetts, New Hampshire, New York.
Frequently Asked Questions
What is clinical trial NCT06908538 about?
NCT06908538 is a clinical study titled "Cryo NerVe Block Extremity AmputatioN RegIStry for Post Operative and pHantom Limb Pain". The goal of this Registry is to see how the device is used when freezing nerves during an amputation procedure.
What is the current status of trial NCT06908538?
This trial is currently recruiting. The enrollment target is 2,000 participants. The study started on 2025-04-01. Estimated completion is 2035-04.
What conditions does trial NCT06908538 study?
This clinical trial studies the following conditions: Amputation, Amputation, Traumatic/Surgery, Amputation of Lower Limb, Amputation, Limb Loss, Amputation of Upper Limb.
What interventions are being tested in trial NCT06908538?
The interventions under investigation include: cryoablation (DEVICE).
Who is sponsoring clinical trial NCT06908538?
This trial is sponsored by AtriCure, which has 23 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06908538 being conducted?
This trial has 4 study locations across Massachusetts, New Hampshire, New York, Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Amputation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06908538's enrollment target sits among peer trials
2,000 1st of 65 the highest of 65 other Amputation trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Amputation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Evaluation of Myoelectric Implantable Recording Array (MIRA) in Participants With Transradial Amputation
RECRUITING · NA
-
Deploying Digital Prosthetic Interface Technology and Exercise in Dysvascular Amputees
RECRUITING · Phase 2
-
Efficacy and Mechanisms of Virtual Reality Treatment of Phantom Leg Pain.Home-Based Treatment
RECRUITING · NA
-
Hand Transplantation
RECRUITING · NA
-
Target Muscle Re-innervation and Regenerative Peripheral Nerve Interfaces Alone and in Combination for the Treatment of Residual and Phantom Limb Pain in Cancer Patients Who Have Received an Amputation
RECRUITING · NA
-
Can an Array of Micro-electrodes Implanted in a Human Nerve Record Neural Signals and Provide Feedback?
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001465 · 2,000 participants
Study of the Disease Process of Lymphangioleiomyomatosis
- NCT00001595 · 2,000 participants
An Investigation of Pituitary Tumors and Related Hypothalmic Disorders
- NCT00138931 · 2,000 participants
Genetics of Cardiovascular and Neuromuscular Disease
- NCT00288119 · 2,000 participants
Genetic Determinants of Barrett's Esophagus and Esophageal Adenocarcinoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI